<DOC>
	<DOC>NCT02087540</DOC>
	<brief_summary>To identify efficacy and safety of Telmisartan/Rosuvastatin co-administration in hyperlipidemia control in hypertensive patients with hyperlipidemia compared to each monotherapy.</brief_summary>
	<brief_title>Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Signed Informed Consent Men and women &gt;18 years of age Subject who has one of 3 conditions classifed by Cardiovascular Risk Factors, 10Year Risk, Blood Pressure, LDLC, Coronary Artery Disease and Equivalent Female who are pregnant, breastfeeding, or of childbearing potential, unwilling to practice adequate contraception throughout the study,. Other exclusions applied</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>